U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

The company, which has been targeted by Washington, saw US revenue jump 28 per cent in the first quarter, compared with 21 ...

SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

Me’s bankruptcy could put millions of Americans’ genomic profiles at risk of being sold to the Chinese Communist Party, who ...

But as China’s biotech scene has shifted from copycat ... China Innovation Center – a digital hub designed to power the company’s strategy in one of its fastest-growing markets.

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Amid rising US-China trade tensions, AdAlta aims to be a gateway for Asia's next wave of cellular immunotherapies to enter ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under massive threat.

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

IN BRIEFUS Patent Office granted Active Biotech's patent application for laquinimod in eye disorders (January 28)Active Biotech announced that the first patient was enrolled in the European ...